Clinical Trials in Salt Lake City

Showing 1101-1120 of 7,997 trials

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

NCT05412992

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Pain, Postoperative

Teikoku Pharma USA, Inc.179 participantsStarted Jul 2022

Anaheim, California, United States • Salt Lake City, Utah, United States

Enrolling By Invitation< 1 mile

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

NCT05506423

This observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of glaucoma medications, and any side effects related to the surgery will be collected from participants' preoperative examination, their surgery, and postoperative examinations.

Open Angle Glaucoma

Iantrek, Inc.300 participantsStarted Aug 2022

Newport Beach, California, United States • Cape Coral, Florida, United States • DeLand, Florida, United States +13 more locations

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Find Trials by Condition in Salt Lake City

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Ribociclib and Letrozole Treatment in Ovarian Cancer

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Lumbar Interbody Implant Study

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

SP Thoracic IDE Study

An Observational Study of Patients With Moderate Parkinson's Disease

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease